Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Codalax Forte
Active Ingredients: Danthron 15mg/mL
Poloxamer 188 200mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Douglas Manufacturing, div. Douglas Pharmaceuticals Limited, Lincoln, Auckland
This consent is given subject to the following condition:
? This medicine may only be used for the prevention or treatment of constipation in the terminally ill.
Note: This consent is valid for two years from 30 July 2002.
Product: Codalax
Active Ingredients: Danthron 5mg/mL
Poloxamer 188 40mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Douglas Manufacturing, div. Douglas Pharmaceuticals Ltd, Lincoln, Auckland
This consent is given subject to the following condition:
? This medicine may only be used for the prevention or treatment of constipation in the terminally ill.
Note: This consent is valid for two years from 30 July 2002.
Dated this 15th day of August 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).